Financial Engines Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$738K Sell
7,133
-130
-2% -$11.6K ﹤0.01% 351
2026
Q1
$522K Sell
7,263
-1,495
-17% -$115K ﹤0.01% 383
2025
Q4
$695K Buy
8,758
+1,922
+28% +$152K ﹤0.01% 359
2025
Q3
$515K Buy
6,836
+123
+2% +$8.43K ﹤0.01% 390
2025
Q2
$463K Sell
6,713
-120
-2% -$7.87K ﹤0.01% 394
2025
Q1
$463K Sell
6,833
-1,331
-16% -$79.7K ﹤0.01% 333
2024
Q4
$366K Buy
+8,164
New +$458K ﹤0.01% 358
2024
Q1
– Sell
-3,119
Closed -$246K – 339
2023
Q4
$246K Buy
+3,119
New +$222K ﹤0.01% 290
2022
Q3
– Sell
-3,836
Closed -$355K – 292
2022
Q2
$355K Buy
+3,836
New +$374K ﹤0.01% 230
2022
Q1
– Sell
-2,263
Closed -$233K – 312
2021
Q4
$233K Sell
2,263
-970
-30% -$89.6K ﹤0.01% 253
2021
Q3
$274K Buy
+3,233
New +$271K ﹤0.01% 226
2021
Q2
– Sell
-3,367
Closed -$253K – 223
2021
Q1
$253K Buy
+3,367
New +$245K ﹤0.01% 230
2018
Q1
– Sell
-17
Closed -$1K – 154
2017
Q4
$1K Buy
+17
New +$1.24K ﹤0.01% 177

Other funds holding CVS

Financial Engines Advisors's CVS Position: Q2 2026 in Review

Financial Engines Advisors reduced its CVS Health (CVS) stake by 1.8% in Q2 2026, selling an estimated $11.6K and leaving 7,133 shares worth $738K. The position accounts for ﹤0.01% of the portfolio, ranked #351.

Financial Engines Advisors first reported a position in CVS in Q4 2017 and has held it in 13 quarters since. 2,074 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Financial Engines Advisors held 7,133 shares of CVS Health worth $738K as of Q2 2026.
  • Financial Engines Advisors sold 130 CVS Health shares in Q2 2026, an estimated $11.6K.
  • CVS Health made up ﹤0.01% of Financial Engines Advisors's portfolio in Q2 2026, its #351 holding.
  • Financial Engines Advisors first reported a position in CVS Health in Q4 2017 and has held it in 13 quarters since.
  • 2,074 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Financial Engines Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.